<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<itunes:new-feed-url>http://media.peerviewpress.com/000136/podcast/pvi/xml/endocrinology_audio.xml</itunes:new-feed-url>
		<atom:link rel="self" href="http://podcast.peerviewpress.com/endocrinology/endocrinologychannel.xml" type="application/rss+xml" />
		<lastBuildDate>Mon, 19 Oct 2009 16:06:45 -0400</lastBuildDate>
		<title>PeerView Endocrinology CME/CNE/CPE Audio Podcast</title>
		<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
		<link>http://www.peerviewpress.com</link>
		<generator>Podcast Maker v1.3.8b - http://www.lemonzdream.com/podcastmaker</generator>
		<description><![CDATA[PeerView Press is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.]]></description>
		<itunes:subtitle>Thought leader perspectives on current clinical advances in medicine</itunes:subtitle>
		<itunes:summary>PeerView Press is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.</itunes:summary>
		<language>en-us</language>
		<copyright>2006</copyright>
		<itunes:owner>
			<itunes:name>PeerView Press, 24 West 40th Street, Suite 950, New York, NY 10018</itunes:name>
			<itunes:email>webmaster@peerviewpress.com</itunes:email>
		</itunes:owner>
		<image>
			<url>http://podcast.peerviewpress.com/endocrinology/podcast_endoCME-CNE-CPE_144.jpg</url>
			<title>PeerView Endocrinology CME/CNE/CPE Audio Podcast</title>
			<link>http://www.peerviewpress.com</link>
			<width>144</width>
			<height>144</height>
		</image>
		<itunes:image href="http://podcast.peerviewpress.com/endocrinology/podcast_endoCME-CNE-CPE.jpg" />
		<category>Science &amp; Medicine</category>
		<itunes:category text="Science &amp; Medicine" />
		<itunes:keywords>CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Endocrinology</itunes:keywords>
		<itunes:explicit>no</itunes:explicit>
		<item>
			<title>Charles A. Cefalu, MD, MS - Optimizing Insulin-Dependent Diabetes Management in Long-Term Care</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in insulin-dependent diabetes discuss the optimal management of patients in long-term care settings.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in insulin-dependent diabetes discuss the optimal management of patients in long-term care settings.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/endocrinology/PPVNE05964r70.mp3" length="28219817" />
			<link>http://podcast.peerviewpress.com/endocrinology/PPVNE05964r70.mp3</link>
			<guid>http://podcast.peerviewpress.com/endocrinology/PPVNE05964r70.mp3</guid>
			<pubDate>Fri, 16 Oct 2009 15:58:42 -0400</pubDate>
			<category>Science &amp; Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:29:22</itunes:duration>
			<itunes:keywords>diabetes, long-term care, nursing home, insulin-dependent diabetes, diabetes management</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - Optimizing Insulin-Dependent Diabetes Management in Long-Term Care</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information.  You will need Adobe Acrobat reader software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information.  You will need Adobe Acrobat reader software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information.  You will need Adobe Acrobat reader software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/endocrinology/PPVNE05964CMEinfo.pdf" length="332883" />
			<link>http://podcast.peerviewpress.com/endocrinology/PPVNE05964CMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/endocrinology/PPVNE05964CMEinfo.pdf</guid>
			<pubDate>Fri, 16 Oct 2009 15:56:24 -0400</pubDate>
			<category>Science &amp; Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>diabetes, long-term care, nursing home, insulin-dependent diabetes, diabetes management</itunes:keywords>
		</item>
		<item>
			<title>Ralph A. DeFronzo, MD - Reducing Cardiovascular Risks and Preserving Beta Cell Function in Patients With Type 2 Diabetes</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, an expert in the management of type 2 diabetes discusses strategies to reduce cardiovascular risk and the rationale for beta cell preservation in patients with type 2 diabetes.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, an expert in the management of type 2 diabetes discusses strategies to reduce cardiovascular risk and the rationale for beta cell preservation in patients with type 2 diabetes.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/endocrinology/PPVNE05803n10.mp3" length="21577458" />
			<link>http://podcast.peerviewpress.com/endocrinology/PPVNE05803n10.mp3</link>
			<guid>http://podcast.peerviewpress.com/endocrinology/PPVNE05803n10.mp3</guid>
			<pubDate>Thu, 17 Sep 2009 15:25:50 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:22:26</itunes:duration>
			<itunes:keywords>diabetes, cardiovascular disease, cardiovascular risk, beta cell function, beta cell</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - Reducing Cardiovascular Risks and Preserving Beta Cell Function in Patients With Type 2 Diabetes</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information.  You will need Adobe Acrobat reader software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information.  You will need Adobe Acrobat reader software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information.  You will need Adobe Acrobat reader software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/endocrinology/PPVNE05803CMEinfo.pdf" length="366826" />
			<link>http://podcast.peerviewpress.com/endocrinology/PPVNE05803CMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/endocrinology/PPVNE05803CMEinfo.pdf</guid>
			<pubDate>Thu, 17 Sep 2009 15:25:46 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>diabetes, cardiovascular disease, cardiovascular risk, beta cell function, beta cell</itunes:keywords>
		</item>
		<item>
			<title>Shlomo Melmed, MD, FRCP - Improving Outcomes in Acromegaly and Cushing’s Disease: Identifying Appropriate Patients for Medical Management</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, an expert in management of pituitary tumors discusses comorbid conditions associated with acromegaly and Cushing’s disease as well as current treatment options for pituitary tumors, focusing on pharmacotherapy.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, an expert in management of pituitary tumors discusses comorbid conditions associated with acromegaly and Cushing’s disease as well as current treatment options for pituitary tumors, focusing on pharmacotherapy.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/endocrinology/PPVNE05806n9.mp3" length="25378433" />
			<link>http://podcast.peerviewpress.com/endocrinology/PPVNE05806n9.mp3</link>
			<guid>http://podcast.peerviewpress.com/endocrinology/PPVNE05806n9.mp3</guid>
			<pubDate>Tue, 01 Sep 2009 16:37:49 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:26:23</itunes:duration>
			<itunes:keywords>acromegaly, Cushing&apos;s disease, pituitary tumor, growth hormone, hypercortisolism, somatostatin receptor ligands, pasireotide, surgery</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE - Improving Outcomes in Acromegaly and Cushing’s Disease: Identifying Appropriate Patients for Medical Management</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/endocrinology/PPVNE05806CMEinfo.pdf" length="731403" />
			<link>http://podcast.peerviewpress.com/endocrinology/PPVNE05806CMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/endocrinology/PPVNE05806CMEinfo.pdf</guid>
			<pubDate>Tue, 01 Sep 2009 16:37:07 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>acromegaly, Cushing&apos;s disease, pituitary tumor, growth hormone, hypercortisolism, somatostatin receptor ligands, pasireotide, surgery</itunes:keywords>
		</item>
		<item>
			<title>Christopher P. Cannon, MD - Optimizing Management of Dyslipidemia: Risk Assessment, Treatment Targets, and Adherence</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in management of dyslipidemia discuss the optimal assessment of cardiovascular risk in patients with dyslipidemia, including the role of novel markers such as hs-CRP; optimal treatment goals based on cardiovascular risk; and strategies to maximize adherence to long-term therapy and lifestyle interventions.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in management of dyslipidemia discuss the optimal assessment of cardiovascular risk in patients with dyslipidemia, including the role of novel markers such as hs-CRP; optimal treatment goals based on cardiovascular risk; and strategies to maximize adherence to long-term therapy and lifestyle interventions.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/endocrinology/PPVNE05992e21.mp3" length="38115148" />
			<link>http://podcast.peerviewpress.com/endocrinology/PPVNE05992e21.mp3</link>
			<guid>http://podcast.peerviewpress.com/endocrinology/PPVNE05992e21.mp3</guid>
			<pubDate>Thu, 20 Aug 2009 16:29:43 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:39:40</itunes:duration>
			<itunes:keywords>dyslipidemia, lipid disorders, hs-CRP, biomarkers, cardiovascular risk, Framingham Risk Score</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - Optimizing Management of Dyslipidemia: Risk Assessment, Treatment Targets, and Adherence</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/endocrinology/PPVNE05992CMEinfo.pdf" length="289805" />
			<link>http://podcast.peerviewpress.com/endocrinology/PPVNE05992CMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/endocrinology/PPVNE05992CMEinfo.pdf</guid>
			<pubDate>Thu, 20 Aug 2009 16:29:38 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>dyslipidemia, lipid disorders, hs-CRP, biomarkers, cardiovascular risk, Framingham Risk Score</itunes:keywords>
		</item>
		<item>
			<title>Vivian A. Fonseca, MD, FRCP - Matching Treatment to Need in Type 2 Diabetes: Using Incretin-Based Oral Therapies Across the Clinical Spectrum</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, an expert in diabetes discusses optimal management strategies in a diabetic patient who has been failing standard therapy and in a treatment-naïve diabetic patient with renal impairment. Other specific challenges, such as minimizing the risk of hypoglycemia, are also explored.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, an expert in diabetes discusses optimal management strategies in a diabetic patient who has been failing standard therapy and in a treatment-naïve diabetic patient with renal impairment. Other specific challenges, such as minimizing the risk of hypoglycemia, are also explored.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/endocrinology/PA05738FCp156.mp3" length="35084248" />
			<link>http://podcast.peerviewpress.com/endocrinology/PA05738FCp156.mp3</link>
			<guid>http://podcast.peerviewpress.com/endocrinology/PA05738FCp156.mp3</guid>
			<pubDate>Thu, 21 May 2009 14:52:25 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:36:30</itunes:duration>
			<itunes:keywords>diabetes, glycemic control, A1C, incretin</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - Matching Treatment to Need in Type 2 Diabetes: Using Incretin-Based Oral Therapies Across the Clinical Spectrum</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/endocrinology/PA05738FCCMEinfo.pdf" length="737562" />
			<link>http://podcast.peerviewpress.com/endocrinology/PA05738FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/endocrinology/PA05738FCCMEinfo.pdf</guid>
			<pubDate>Thu, 21 May 2009 14:52:23 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>diabetes, glycemic control, A1C, incretin</itunes:keywords>
		</item>
		<item>
			<title>John G. Bartlett, MD - DHHS Guidelines Update: Improving Outcomes in HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the management of HIV discuss the clinical implications of the latest updates to the DHHS guidelines.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the management of HIV discuss the clinical implications of the latest updates to the DHHS guidelines.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/endocrinology/PA05393FCr439.mp3" length="25455166" />
			<link>http://podcast.peerviewpress.com/endocrinology/PA05393FCr439.mp3</link>
			<guid>http://podcast.peerviewpress.com/endocrinology/PA05393FCr439.mp3</guid>
			<pubDate>Tue, 21 Apr 2009 15:19:41 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:26:28</itunes:duration>
			<itunes:keywords>HIV; DHHS guidelines; HIV guidelines; ART; antiretroviral therapy</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - DHHS Guidelines Update: Improving Outcomes in HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/endocrinology/PA05393FCCMEinfo.pdf" length="705917" />
			<link>http://podcast.peerviewpress.com/endocrinology/PA05393FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/endocrinology/PA05393FCCMEinfo.pdf</guid>
			<pubDate>Tue, 21 Apr 2009 15:19:39 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>HIV; DHHS guidelines; HIV guidelines; ART; antiretroviral therapy</itunes:keywords>
		</item>
		<item>
			<title>Louis Monnier, MD - A Debate on Glycaemic Control in Type 2 Diabetes: Maintaining Target A1c, Postmeal Glucose, and Therapy Selection</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the management of type 2 diabetes discuss the role of postprandial hyperglycaemia in achieving optimal glycaemic control and reducing the risk of cardiovascular events.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the management of type 2 diabetes discuss the role of postprandial hyperglycaemia in achieving optimal glycaemic control and reducing the risk of cardiovascular events.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/endocrinology/PI04742FCe025.mp3" length="43734733" />
			<link>http://podcast.peerviewpress.com/endocrinology/PI04742FCe025.mp3</link>
			<guid>http://podcast.peerviewpress.com/endocrinology/PI04742FCe025.mp3</guid>
			<pubDate>Thu, 16 Apr 2009 15:42:12 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:45:31</itunes:duration>
			<itunes:keywords>type 2 diabetes, hyperglycaemia, hypoglycaemia, postprandial glucose, glycaemic control,  monitoring, cardiovascular disease</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - A Debate on Glycaemic Control in Type 2 Diabetes: Maintaining Target A1c, Postmeal Glucose, and Therapy Selection</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/endocrinology/PI04742FCCMEinfo.pdf" length="304013" />
			<link>http://podcast.peerviewpress.com/endocrinology/PI04742FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/endocrinology/PI04742FCCMEinfo.pdf</guid>
			<pubDate>Thu, 16 Apr 2009 15:42:10 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>type 2 diabetes, hyperglycaemia, hypoglycaemia, postprandial glucose, glycaemic control,  monitoring, cardiovascular disease</itunes:keywords>
		</item>
		<item>
			<title>William A. O’Brien, MD - Treatment Guideline Update: Improving Cardiovascular and Metabolic Outcomes in Patients With HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, two leading experts in the area of HIV management will analyze the latest treatment guidelines for managing metabolic and cardiovascular risk in patients with HIV. Topics in these discussions include cardiovascular and metabolic considerations for individualizing therapy, treatment selection, and insight regarding switching therapies. In addition, practical considerations for the screening, monitoring, and management of these comorbidities in patients with HIV will be discussed.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, two leading experts in the area of HIV management will analyze the latest treatment guidelines for managing metabolic and cardiovascular risk in patients with HIV. Topics in these discussions include cardiovascular and metabolic considerations for individualizing therapy, treatment selection, and insight regarding switching therapies. In addition, practical considerations for the screening, monitoring, and management of these comorbidities in patients with HIV will be discussed.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/endocrinology/PA04256FCr431.mp3" length="29494422" />
			<link>http://podcast.peerviewpress.com/Endocrinology/PA04256FCr431.mp3</link>
			<guid>http://podcast.peerviewpress.com/endocrinology/PA04256FCr431.mp3</guid>
			<pubDate>Tue, 24 Mar 2009 14:42:21 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:30:41</itunes:duration>
			<itunes:keywords>HIV; DHHS guidelines; guidelines; ART; antiretroviral therapy; cardiovascular risk; metabolic syndrome</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - Treatment Guideline Update: Improving Cardiovascular and Metabolic Outcomes in Patients With HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/endocrinology/PA04256FCCMEinfo.pdf" length="727769" />
			<link>http://podcast.peerviewpress.com/Endocrinology/PA04256FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/endocrinology/PA04256FCCMEinfo.pdf</guid>
			<pubDate>Tue, 24 Mar 2009 14:42:18 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>HIV; DHHS guidelines; guidelines; ART; antiretroviral therapy; cardiovascular risk; metabolic syndrome</itunes:keywords>
		</item>
		<item>
			<title>Brett R. Stacey, MD - A Case-Based Approach to Recognizing and Managing Diabetic Peripheral Neuropathy</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, an expert in painful DPN discusses differential diagnosis of the condition and management approaches in treatment-naïve patients as well as in individuals with established diagnosis.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, an expert in painful DPN discusses differential diagnosis of the condition and management approaches in treatment-naïve patients as well as in individuals with established diagnosis.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/endocrinology/PA05052FCp151.mp3" length="26580791" />
			<link>http://podcast.peerviewpress.com/Endocrinology/PA05052FCp151.mp3</link>
			<guid>http://podcast.peerviewpress.com/endocrinology/PA05052FCp151.mp3</guid>
			<pubDate>Mon, 09 Mar 2009 14:03:52 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:27:39</itunes:duration>
			<itunes:keywords>diabetic peripheral neuropathy, DPN, diabetes, neuropathic pain, nerve damage, pregabalin, duloxetine, diagnosis</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - A Case-Based Approach to Recognizing and Managing Diabetic Peripheral Neuropathy</title>
			<itunes:author>PeerView Press</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/endocrinology/PA05052FCCMEinfo.pdf" length="705388" />
			<link>http://podcast.peerviewpress.com/Endocrinology/PA05052FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/endocrinology/PA05052FCCMEinfo.pdf</guid>
			<pubDate>Mon, 09 Mar 2009 14:03:48 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>diabetic peripheral neuropathy, DPN, diabetes, neuropathic pain, nerve damage, pregabalin, duloxetine, diagnosis</itunes:keywords>
		</item>
		<item>
			<title>Jorge Luiz Gross, MD - Clinical Potential of Emerging Treatments in Type 2 Diabetes: Focus on Glycaemic Control and DPP-4 Inhibition</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the management of type 2 diabetes discuss aspects of novel glucose-lowering therapies in the overall context of optimal disease management.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the management of type 2 diabetes discuss aspects of novel glucose-lowering therapies in the overall context of optimal disease management.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/endocrinology/PI04741FCr444.mp3" length="45755982" />
			<link>http://podcast.peerviewpress.com/Endocrinology/PI04741FCr444.mp3</link>
			<guid>http://podcast.peerviewpress.com/endocrinology/PI04741FCr444.mp3</guid>
			<pubDate>Thu, 26 Feb 2009 16:38:45 -0500</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:47:37</itunes:duration>
			<itunes:keywords>diabetes, DPP-4, incretin, hypoglycaemia, A1C, ACCORD, ADVANCE, metformin, EASD, ADA, saxagliptin, sitagliptin</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE - Clinical Potential of Emerging Treatments in Type 2 Diabetes: Focus on Glycaemic Control and DPP-4 Inhibition</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/endocrinology/PI04741FCCMEinfo.pdf" length="716671" />
			<link>http://podcast.peerviewpress.com/Endocrinology/PI04741FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/endocrinology/PI04741FCCMEinfo.pdf</guid>
			<pubDate>Thu, 26 Feb 2009 16:38:43 -0500</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>diabetes, DPP-4, incretin, hypoglycaemia, A1C, ACCORD, ADVANCE, metformin, EASD, ADA, saxagliptin, sitagliptin</itunes:keywords>
		</item>
		<item>
			<title>Donald P. Kotler, MD - Understanding Metabolic Dysfunction in HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts review the association between HIV disease, antiretroviral therapy, and the risk for metabolic dysfunction in patients with HIV. A review of the most appropriate management strategies for metabolic dysfunction in this patient population is featured.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file or full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts review the association between HIV disease, antiretroviral therapy, and the risk for metabolic dysfunction in patients with HIV. A review of the most appropriate management strategies for metabolic dysfunction in this patient population is featured.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/endocrinology/PA04255FCr403.mp3" length="23747871" />
			<link>http://podcast.peerviewpress.com/Endocrinology/PA04255FCr403.mp3</link>
			<guid>http://podcast.peerviewpress.com/endocrinology/PA04255FCr403.mp3</guid>
			<pubDate>Tue, 25 Nov 2008 15:15:55 -0500</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:24:39</itunes:duration>
			<itunes:keywords>HIV, metabolic syndrome, cardiovascular disease, ATAZIP, COMET, SWEET, dyslipidemia, PI, atherosclerosis, NNRTI, HAART, BICOMBO</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Understanding Metabolic Dysfunction in HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file.</itunes:subtitle>
			<itunes:summary />
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/endocrinology/PA04255FCCMEinfo.pdf" length="281021" />
			<link>http://podcast.peerviewpress.com/Endocrinology/PA04255FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/endocrinology/PA04255FCCMEinfo.pdf</guid>
			<pubDate>Thu, 31 Jul 2008 15:15:54 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>HIV, metabolic syndrome, cardiovascular disease, ATAZIP, COMET, SWEET, dyslipidemia, PI, atherosclerosis, NNRTI, HAART, BICOMBO</itunes:keywords>
		</item>
		<item>
			<title>Edward Horton, MD - The Role of Incretin-Based Therapy in Managing Type 2 Diabetes</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the treatment of diabetes explore the use of incretin-based therapies in the management of this condition. An assessment of data from the 68th Scientific Sessions of the American Diabetes Association is featured. ]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file or full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the treatment of diabetes explore the use of incretin-based therapies in the management of this condition. An assessment of data from the 68th Scientific Sessions of the American Diabetes Association is featured. </itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/endocrinology/PA04206FCe020.mp3" length="32275368" />
			<link>http://podcast.peerviewpress.com/Endocrinology/PA04206FCe020.mp3</link>
			<guid>http://podcast.peerviewpress.com/endocrinology/PA04206FCe020.mp3</guid>
			<pubDate>Mon, 14 Jul 2008 15:27:46 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:33:35</itunes:duration>
			<itunes:keywords>diabetes, incretin, beta-cell, DPP-IV inhibitors, GLP-1, GIP, sitagliptin, exenatide, liraglutide, alogliptin</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - The Role of Incretin-Based Therapy in Managing Type 2 Diabetes</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/endocrinology/PA04206FCCMEinfo.pdf" length="264409" />
			<link>http://podcast.peerviewpress.com/Endocrinology/PA04206FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/endocrinology/PA04206FCCMEinfo.pdf</guid>
			<pubDate>Mon, 14 Jul 2008 15:27:45 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>diabetes, incretin, beta-cell, DPP-IV inhibitors, GLP-1, GIP, sitagliptin, exenatide, liraglutide, alogliptin</itunes:keywords>
		</item>
		<item>
			<title>Steven V. Edelman, MD - Beyond Glycemic Control: Managing Obesity and Cardiovascular Disease Risk for Patients With Type 2 Diabetes in the Primary Care Setting</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, an expert in the treatment of diabetes investigates the importance of addressing the many cardiometabolic risk factors that are present in patients with type 2 diabetes. The activity also features an analysis of the impact of newer antidiabetic agents, including incretin mimetics and DPP-IV inhibitors, on improving a number of these risk factors.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file or full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, an expert in the treatment of diabetes investigates the importance of addressing the many cardiometabolic risk factors that are present in patients with type 2 diabetes. The activity also features an analysis of the impact of newer antidiabetic agents, including incretin mimetics and DPP-IV inhibitors, on improving a number of these risk factors.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/endocrinology/PA04817FCn186.mp3" length="23569117" />
			<link>http://podcast.peerviewpress.com/Endocrinology/PA04817FCn186.mp3</link>
			<guid>http://podcast.peerviewpress.com/endocrinology/PA04817FCn186.mp3</guid>
			<pubDate>Wed, 02 Jul 2008 14:02:06 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:24:31</itunes:duration>
			<itunes:keywords>Diabetes, exenatide, sitagliptin, 68th Scientific Sessions of the American Diabetes Association, GLP-1 receptor agonists, DPP-IV inhibitors, obesity, cardiovascular disease</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Beyond Glycemic Control: Managing Obesity and Cardiovascular Disease Risk for Patients With Type 2 Diabetes in the Primary Care Setting</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/endocrinology/PA04817FCCMEinfo.pdf" length="279464" />
			<link>http://podcast.peerviewpress.com/Endocrinology/PA04817FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/endocrinology/PA04817FCCMEinfo.pdf</guid>
			<pubDate>Wed, 02 Jul 2008 14:02:04 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>Diabetes, exenatide, sitagliptin, 68th Scientific Sessions of the American Diabetes Association, GLP-1 receptor agonists, DPP-IV inhibitors, obesity, cardiovascular disease</itunes:keywords>
		</item>
	</channel>
</rss>